U.S. flag

An official website of the United States government

NM_021814.5(ELOVL5):c.247-15_247-14delinsGC AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Feb 9, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003882529.1

Allele description [Variation Report for NM_021814.5(ELOVL5):c.247-15_247-14delinsGC]

NM_021814.5(ELOVL5):c.247-15_247-14delinsGC

Gene:
ELOVL5:ELOVL fatty acid elongase 5 [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
6p12.1
Genomic location:
Preferred name:
NM_021814.5(ELOVL5):c.247-15_247-14delinsGC
HGVS:
  • NC_000006.12:g.53276270_53276271delinsGC
  • NG_034263.1:g.77909_77910delinsGC
  • NM_001242828.2:c.328-15_328-14delinsGC
  • NM_001242830.2:c.247-15_247-14delinsGC
  • NM_001301856.2:c.247-15_247-14delinsGC
  • NM_021814.5:c.247-15_247-14delinsGCMANE SELECT
  • NC_000006.11:g.53141068_53141069delinsGC
Molecular consequence:
  • NM_001242828.2:c.328-15_328-14delinsGC - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001242830.2:c.247-15_247-14delinsGC - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001301856.2:c.247-15_247-14delinsGC - intron variant - [Sequence Ontology: SO:0001627]
  • NM_021814.5:c.247-15_247-14delinsGC - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004687614Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Feb 9, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV004687614.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Experimental studies and prediction algorithms are not available or were not evaluated, and the effect of this variant on mRNA splicing is currently unknown. This variant has not been reported in the literature in individuals affected with ELOVL5-related conditions. Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This sequence change falls in intron 3 of the ELOVL5 gene. It does not directly change the encoded amino acid sequence of the ELOVL5 protein. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 5, 2024